Hayakawa, Sho, et al. “Efficacy of Recombinant Human Soluble Thrombomodulin for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Single Arm, Non-Randomized Prospective Clinical Trial”. Multidisciplinary Respiratory Medicine, vol. 11, no. 1, Nov. 2016, https://doi.org/10.4081/mrm.2016.343.